SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

Small lymphocytic lymphoma (SLL) is a slow-growing cancer of the immune system. It is typically manageable with treatment, but outlook can depend on a few factors. SLL is one type of non-Hodgkin ...

Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what ...

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 4, 2025 /EINPresswire / -- The small lymphocytic lymphoma market is predicted to experience steady growth in the coming years, forecasted to increase ...

In the U.S., BREYANZI is approved for treating relapsed or refractory large B-cell lymphoma (LBCL) after at least one prior ...

The drug has been approved for relapsed/refractory (r/r) CLL/SLL, r/r marginal zone lymphoma and r/r mantle cell lymphoma on China's National Reimbursement Drug List. InnoCare Pharma focuses on ...

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are very similar because they have the same type of ...

Background: Small lymphocytic lymphoma is a relatively rare B-cell non-Hodgkin lymphoma that is considered to be the tissue equivalent of the much more common entity chronic lymphocytic leukemia.

CLL or SLL in people who have received a prior Bruton’s tyrosine kinase (BTK) inhibitor and B-cell lymphoma 2 (BCL-2) treatment plan. Jaypirca starts working soon after you start taking the ...

Bexobrutideg, a first-in-class Bruton’s tyrosine kinase degrader, has been granted orphan drug designation from the FDA in ...

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL ...